Electron microscope studies been made of mock-infected or herpes simplex virus (HSV) type 1 (strain 17)-or HSV-2 (strain HG52)-infected Flow 2002 cells grown in the absence or presence of various concentrations of cicloxolone sodium (CCX). Fifty nonserial, thin sections of mock-infected or HSV-infected cells, which contained a portion of the nucleus, were examined by transmission electron microscopy. With increasing drug concentration, counts of capsid structures both in the nucleus and cytoplasm showed a decrease in the number of virions per cell section, an increase in the ratio of nuclear to cytoplasmic virus, a relative reduction in the percentage of cytoplasmic enveloped virus particles, but no effect on the ratio of empty to core-containing capsid structures. The high particle to p.f.u, ratio induced by CCX treatment is thus not explained through failure to assemble morphologically mature core-containing capsids. In part it can be explained by non-envelopment, but in addition, specific effects on other virion proteins (tegument and envelope) must be involved. The extracellular virus particle yield was unaffected, indicating that CCX treatment enhances the egress of HSV. In the presence of CCX the encapsidation of HSV DNA into DNase-resistant structures was unaffected.
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A very high particle/p.f.u, ratio characterizes the antiviral effect against herpes simplex virus (HSV) of the triterpenoid compound cicloxolone sodium (CCX), and is regarded as being largely due to the assembly of poor quality virus particles with an abnormal composition of tegument and envelope proteins (Dargan & Subak-Sharpe, 1986a, b) . We have investigated the maturation of both HSV-1 (strain 17) and HSV-2 (strain HG52) virions in CCX-treated cells by transmission electron microscopy to answer two questions: first, could the unusual structural protein composition of the yield of virus produced in the presence of CCX be due to the synthesis of an excess of aberrant capsid structures and second, does CCX operate through a block on virion assembly or release?
The morphological changes induced by HSV-1 (strain 17) and HSV-2 (strain HG52) infection of cells have been described (Dargan & Subak-Sharpe, 1983; Atkinson et al., 1978) and stages in the virus replication cycle have been identified from studies using temperature-sensitive mutants grown at the non-permissive temperature. In the presence of CCX all of the characteristic ultrastructural changes associated with these strains of HSV-1 and HSV-2 were observed: marginated chromatin, distorted nuclear membrane, intranuclear granular accumulations, empty, partially filled and dense-cored nucleocapsids and enveloped virus particles (Atkinson et al., 1978; Dargan & Subak-Sharpe, 1983 ). However, they occurred with decreasing frequency as the drug concentration increased. The additional ultrastructural changes previously found only in HSV-2-infected cells were also observed: intranuclear ring-like components and nuclear and cytoplasmic microtubules (Atkinson et al., 1978) . Thus no evidence has been obtained to suggest that CCX treatment arrests HSV replication at any particular stage in the virus growth cycle, which is in keeping with our earlier conclusions based on virological data (Dargan & Subak-Sharpe, 1985) . However, the reduplication of nuclear and cytoplasmic membranes was not observed in HSV-1-and HSV-2-infected cells treated with either 200 or 300 ~M-CCX, and at both 50 and 100 lt.tM only small amounts of membrane reduplication were seen.
Although no block in the virus replication cycle was detected by electron microscopy, the high particle/p.f.u, ratios generated by CCX treatment indicated an antiviral effect somehow affecting virus maturation. To study maturation we observed the morphology and cell location of individual virus particles in the presence and absence of the drug. The types and location of virus capsid structures were scored in 50 non-serial thin sections of infected cells exhibiting a nucleus and treated with increasing concentrations of CCX.
The proportion of cell sections containing virus particles and the average number of virus particles/section both decreased with increasing drug concentration (Table 1 , columns 2 and 3). These data show that fewer virus particles are assembled in each infected cell. The alternative, that an increasing number of cells in the population fail to make any virus, is ruled out by the range observed on the sections.
The capsid type (cored or empty), location and number of virus particles at each CCX concentration in the 50 cell sections are shown in Table 2 . No aberrant capsid-related structures were identified in any of the cell sections examined, so that explanation for our first question must be dismissed. It is concluded that there is, first, no evidence of an increase in the proportion of empty capsids (Table 2, column 5), second, a reduction in the numbers of core-containing (and also empty) capsids in the cytoplasm ( Table 2 , columns 8 and 9) and, third, a CCX concentration-dependent reduction in total capsid number (Table 2, column 2). HSV-1 and HSV-2 showed similar trends, although the effect of CCX on total capsid number manifested earlier and was more pronounced with HSV-1. The dose-response control (not shown) confirmed that infectivity of HSV-2 was reduced more rapidly (Dargan & Subak-Sharpe, 1985) . The experimental results (Table 2 , column 2) demonstrate that the greater sensitivity of HSV-2 to the antiviral effect of CCX could not stem from comparatively less efficient capsid production by HSV-2. The increased HSV-2 sensitivity must be due to a specific genetic difference between the types which affects particle infectivity but does not differentially affect particle assembly. We are trying to identify and map this genetic difference.
The percentage of total virus particles present in the cytoplasm decreases with increasing CCX concentration both for HSV-1 and HSV-2, but the decrease is more dramatic with type 2 (Table 2, column 9). This implies that virus release from the nucleus through the nuclear membrane is inhibited by the drug, or that transport through the cytoplasm to the extracellular space is accelerated, or that cytoplasmic particles in the presence of CCX are less stable and become degraded. No morphological evidence for particle degradation was obtained, which would seem to rule out the last explanation. Examination of the infected cell supernatant drawn off prior to processing for electron microscopy revealed the expected increase in particle/p.f.u. ratio (Table 1, column 5), but no change in the total number of virus particles released into the medium (Table 1 , column 4). We are forced to the conclusion that the presence of CCX accelerates the intracellular transport and release of HSV. The alternative remaining explanation, that CCX treatment induced more cell lysis, is excluded by the following considerations. First, viability of mock-infected cells (measured by trypan blue dye exclusion) was unchanged (about 95 ~) up to 200 !aM-CCX, and only slightly lowered (89 ~) by 300 laM-CCX treatment. Second, it might be argued that infected cells in the presence of CCX lyse sooner than mock-infected drug-treated cells. However, previous experiments measuring excreted labelled protein from infected and uninfected BHK and Flow 2002 cells show insufficient differences to support this explanation (see Fig. 8 in Dargan & Subak-Sharpe, 1986a) . Third, it might still be argued that if there is a large difference between intracellular and extracellular virus then a small fraction of the cells undergoing early lysis could dramatically raise the level of extracellular virus. However, we have previously shown (Table 5 , columns 4 and 5 in Dargan & Subak-Sharpe, 1985) that 24 h after exposure to CCX, the ratio of intracellular to extracellular virus is 1 : 1 for HSV-1 and 3 : 1 for HSV-2. Thus the last possibility cannot be the explanation for the observed difference, nor can the data be explained in terms of remaining input virus, as the infected cell monolayers were washed twice after the adsorption period. HSV-2 * Flow 2002 cell monolayers were infected with HSV-I or HSV-2 at an m.o.i, of 5 p.f.u./cell, allowed to adsorb for 1 h at 37 °C, washed twice with Eagle's MEM to remove unbound virus and overlaid with Eagle's MEM with 2~o foetal calf serum containing either no drug or various concentrations of CCX. After 24 h incubation at 37 °C, selected plates were harvested for infectivity assay or processed for electron microscopy. The growth medium was removed from the monolayers and assayed for infectivity and virus particle numbers. The monolayers were fixed with 1 ~ osmium tetroxide in phosphate-buffered saline for 1 h, then dehydrated through a series of increasing alcohol concentrations and embedded in situ with Epon resin. After hardening, the monolayers were re-embedded in the standard way. Gold sections were cut with a glass knife, stained with uranyl acetate and counter-stained with lead citrate. The electron microscope used was a JEOL 100S operating at an accelerating voltage of 80 kV.
"{" Range of values in parentheses. To establish whether CCX treatment affects particle envelopment, 50 further cell sections were examined at each drug concentration for enveloped cytoplasmic virus (Table 3 ). The percentage of enveloped HSV-I in the cytoplasm decreased with increasing drug concentration and HSV-2 appeared to exhibit a similar trend. It is noteworthy that with HSV-2, even in the absence of the drug, only 37.7~ of cytoplasmic particles were enveloped. Other experiments (data not shown) examining the percentage of cell-associated and cell-released enveloped virus support the conclusion that CCX treatment reduces the percentage of enveloped virus particles. Thus CCX treatment inhibits the envelopment stage in virion maturation either directly or indirectly. Nevertheless the substantial but limited inhibition of virus envelopment by CCX cannot by itself explain the dramatic loss (10 000-to 100 000-fold)of infectivity (control data, not shown).
Virus
HSV-1 HSV-2 The progressively increasing particle/p.f.u, ratio in the presence of the triterpenoid compounds might also be a consequence of inhibition of a stage in virus DNA packaging. Unfortunately it was not possible to assess using the electron microscope the effect of CCX on encapsidation of HSV DNA, because one could not confidently distinguish between virus particles having none and having a small amount of DNA. DNase resistance of extracts from HSV-l-infected cells grown in the presence or absence of CCX was therefore investigated (encapsidated DNA is expected to be resistant to DNase 1 degradation).
Initially we determined whether the capsid structures made in the presence of CCX were permeable to the enzyme. The cell-associated infectious virus made in BHK cells treated with various concentrations of CCX was incubated with DNase 1 (Fig. 1) . The results showed that the infectious virus made in the presence of at least 200 ~tM-CCX had the same DNase 1 resistance as control virus. The apparent 30-fold reduction in infectivity found with the 300 ~tM-CCX sample probably reflected the heat lability of virus made in the presence of 300 ~tM-CCX (Dargan & Subak-Sharpe, 1986a) .
To examine the effect of CCX on packaging of HSV-1 DNA, total infected cell DNA and DNase 1-resistant cell-associated DNA were extracted by the method of Stow et al. (1983) . After cleavage with BglII, the DNA fragments were separated on a 0.6~ agarose gel, transferred to nitrocellulose and then hybridized with HSV-1 nick-translated DNA probe labelled with [32p]dCTP. After washing, the nitrocellulose was dried and autoradiographed (Fig. 2) . The Southern blots indicate that packaging of HSV-1 DNA (here defined as resistance to DNase 1) is not inhibited by treatment with 150 ~tM-or 300 ~tM-CCX. The expected presence of concatemeric DNA in the DNA extracted (without DNase 1 treatment) from total infected cells is evidenced by over-abundance of the joint fragments a, b, c and e.
The sensitivity of the system is indicated by detection of the input virus DNA in the total infected cell DNA (lane 1). This important control represents DNA extracted from drug-free infected cells immediately after the 1 h absorption period and two washes. The lack of detection of DNase 1-resistant DNA in the input virus control (lane 5) suggests that most or all virus particles have been uncoated.
The high particle/p.f.u, ratios for HSV-1 and HSV-2 which characterize the triterpenoid antiviral activity do not result from the production of either aberrant recognizable capsidrelated structures or capsids lacking a core. Encapsidation of HSV DNA (at least to a stage resistant to DNase 1 treatment) appears to be unaffected by CCX treatment (Fig. 2) . As the number of capsids produced in the cells in the presence of 300 ~tM-CCX is reduced about 30-fold (Table 2, column 2) it seems likely that some of the 'packaged' DNase 1-resistant cell-associated viral DNA is present in forms undetectable as virus particles using the electron microscope. This cell-associated DNA is presumably protected by coating with protein and may represent a precursor form of the virus particle or a drug-induced protectively coated by-product. The envelopment of HSV particles is strongly inhibited (Table 3) , which must contribute to the overall antiviral effect of the drug but cannot explain the whole anti-HSV effect. We have previously shown that HSV produced in the presence of CCX exhibits an abnormal set of tegument and envelope proteins (Dargan & Subak-Sharpe, 1986a) . As acquisition of tegument proteins is a requirement for successful envelopment, disturbance in tegument assembly is likely to reduce the percentage of infectious enveloped virus. Even the enveloped virus made in the presence of CCX is of inferior quality to that made in the absence of the drug as shown by its increased heat lability (Dargan & Subak-Sharpe, 1986a) .
We have previously documented the accumulation of certain viral polypeptides in the nucleus of drug-treated HSV-infected cells (Vmw 145, 87/85, 67, 65/64, 43 and 28K; Dargan & Subak-Sharpe, 1986a, b and unpublished results) . This was not considered to result from increased protein synthesis; there was no equivalent increase in the cytoplasm. The data presented here suggest that the polypeptide accumulation stems from restriction at assembly of virions in the nucleus (Table 2 , columns 3 and 6). Such restriction could arise due to the preferential effect of CCX treatment on one, or more, rate-limiting virus-specified or even cell-specified proteins directly or indirectly needed for particle assembly. The expected result would be preferential accumulation in the nucleus of those virus structural proteins which are most stable.
